The Future of Ketamine and Mood Disorders In 2019, the FDA and European Fee authorized the use of an esketamine nasal spready under the model name Spravato to deal with despair. Even so, as of 2021, ketamine hasn't been accepted through the FDA to deal with depression or other psychological well being disorders, and for that reason, the medication